|
Volumn 44, Issue 2, 2008, Pages 133-145
|
Drospirenone/ethinyl estradiol
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYPROTERONE ACETATE;
DESOGESTREL;
DROSPIRENONE PLUS ETHINYLESTRADIOL;
ETYNODIOL DIACETATE;
GESTODENE;
GONADORELIN;
LEVONORGESTREL;
LUTEINIZING HORMONE;
NORETHISTERONE;
NORETHISTERONE ACETATE;
NORGESTIMATE;
NORGESTREL;
ORAL CONTRACEPTIVE AGENT;
PERFLUTREN;
PROGESTERONE;
SEX HORMONE BINDING GLOBULIN;
SPIRONOLACTONE;
TESTOSTERONE DERIVATIVE;
TRANSCORTIN;
YASMINELLE;
YAZ;
ACNE;
AREA UNDER THE CURVE;
BREAST TENDERNESS;
CLINICAL TRIAL;
DEPRESSION;
DRUG ABSORPTION;
DRUG CONTRAINDICATION;
DRUG METABOLISM;
DYSMENORRHEA;
HEADACHE;
HORMONAL CONTRACEPTION;
HUMAN;
HYPERKALEMIA;
LIBIDO DISORDER;
LOW DRUG DOSE;
MASTALGIA;
MAXIMUM PLASMA CONCENTRATION;
MENSTRUAL IRREGULARITY;
NAUSEA;
ORAL CONTRACEPTION;
PREMENSTRUAL DYSPHORIC DISORDER;
PREMENSTRUAL SYNDROME;
REVIEW;
SIDE EFFECT;
SODIUM RETENTION;
VENOUS THROMBOEMBOLISM;
WATER RETENTION;
WEIGHT GAIN;
ACNE VULGARIS;
ANDROSTENES;
CONTRACEPTIVES, ORAL, COMBINED;
ETHINYL ESTRADIOL;
FEMALE;
HUMANS;
PREMENSTRUAL SYNDROME;
|
EID: 42549151661
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2008.44.2.1191057 Document Type: Review |
Times cited : (12)
|
References (73)
|